Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for cannabis dependence
NCT02044809Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in cannabis use disorder (CUD), sponsored by University College London. Started Mar 2014; status: completed.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT02044809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044809.